Article content
Beyond the runway, the Cashmere team proudly participated in the Canadian Cancer Society CIBC Run for the Cure, standing alongside thousands of Canadians to honour survivors, support those currently facing breast cancer, and raise critical funds for research and care.
Article content
“Every vote, every design, and every act of support brings us closer to a future without breast cancer. The Cashmere Collection is more than fashion, it’s a movement of hope and compassion that empowers Canadians to stand together for change. We are deeply grateful for this partnership and the impact it continues to make in our communities for people affected by breast cancer.” – Andrea Seale, CEO, Canadian Cancer Society.
Article content
This year the Cashmere Collection also made an appearance in Montreal, celebrating local designers and connecting with a new audience in Quebec, where Cashmere is proudly made.
Article content
“The 2025 edition of the Cashmere Collection in Montreal marks a significant milestone in our mission”, said Karine-Iseult Ippersiel, Chief Executive Officer, Quebec Breast Cancer Foundation. “This partnership allows us to further raise awareness among the Quebec population while supporting research initiatives and concrete support programs for those affected by breast cancer.”
Article content
Article content
As the Cashmere Collection looks ahead to its 23rd year, the brand remains committed to celebrating Canadian creativity while championing the cause of breast cancer awareness and research. With each year’s collection, Cashmere continues to prove that when fashion meets compassion, the impact is truly meaningful.
Article content
About the Cashmere Collection
Founded in 2004, the international award-winning Cashmere Collection is an ardent supporter of Canada’s fashion design community and the breast cancer cause. Many of the greatest names in Canadian fashion have contributed to the collection, including Marie Saint Pierre, Greta Constantine, Denis Gagnon, David Dixon, Rudsak, NARCES, Stephan Caras, Lucian Matis, Rodney Philpott and many more.
Article content
Over the last 22 years, Cashmere Collection has raised almost $5.5 million dollars in support of breast cancer awareness, prevention, and treatment programs for its charitable partners, the Canadian Cancer Society (CCS) and the Quebec Breast Cancer Foundation (QBCF).
Article content
About Cashmere and Kruger Products Inc.
Cashmere Bathroom Tissue, Canada’s best-selling tissue brand, reflects Kruger Products’ commitment to providing the finest quality, Canadian-made bathroom tissue products to consumers. Kruger Products is Canada’s leading manufacturer of quality tissue products for household, industrial and commercial use. Kruger Products serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®‘, White Swan®, and Bonterra®. Kruger Products has approximately 3,000 employees and operates 10 FSC® COC-certified (FSC® C104904) production facilities in North America. For more information, visit www.krugerproducts.ca.
Article content
Article content
A longstanding and committed contributor to the breast cancer cause, Kruger Products Inc. has supported the Canadian Breast Cancer Foundation (CBCF), now part of the Canadian Cancer Society (CCS) since 2004 and is currently one of the top five national partners supporting the breast cancer cause at CCS. Kruger Products Inc. is also among the leading contributors to the Quebec Breast Cancer Foundation.
Article content
About the Canadian Cancer Society
The Canadian Cancer Society (CCS) works tirelessly to save and improve lives. We raise funds to fuel the brightest minds in cancer research. We provide a compassionate support system for all those affected by cancer, across Canada and for all types of cancer. Together with patients, supporters, donors and volunteers, we work to create a healthier future for everyone. Because to take on cancer, it takes all of us. It takes a society.
Article content
CCS is the largest national charitable funder of breast cancer research in Canada. Since its peak in the late 1980s, the breast cancer death rate in women has been nearly cut in half. This decline in breast cancer mortality reflects the impact of life-changing research that has led to improvements in screening and treatment for breast cancer. More work needs to be done as breast cancer is still the most commonly diagnosed cancer and the second leading cause of cancer-related deaths among women in Canada. Funds raised through this partnership will be invested in CCS’s leading breast cancer research and support programs.

2 hours ago
2
English (US)